PHARMACEUTICAL MARKET RESEARCH REPORTS
Industry Standard Research – ISR Reports – is a full-service pharmaceutical market research company operating exclusively in the life sciences industry and a sister company of Outsourced Pharma. Their syndicated and custom market research capabilities enable their customers to make smarter, more informed business decisions. You’ll find links to their pharmaceutical market syndicated research reports below.
ISR's market research reports are produced using direct feedback from decision-makers, which enables ISR to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to their customers. Each report is available to purchase online and you may also download free preview files. If you have any questions, please feel free to email info@ISRreports.com.
TRENDS AND MARKET OUTLOOK REPORTS
Emerging Biopharma Perspective On Highly Potent API Manufacturing Market
An overview of the current market dynamics for high containment manufacturing from the perspective of HPAPI manufacturing decision-makers at sponsor organizations at small and midsize biopharmaceutical companies and their predictions on what the market will look like in five years.
Highly Potent API Market Outlook
This report provides an overview of the current market dynamics for high containment manufacturing as well as an outlook on what some HPAPI manufacturing decision-makers at sponsor organizations predict the marketplace will look like five years from now.
Cell & Gene Therapies Market Outlook
Outsourcing decision-makers for cell or gene therapies at sponsor organizations give an overview of the current market dynamics in the cell & gene therapies contract manufacturing space and predictions through 2026.
Sterile Injectable Drug Product Manufacturing Market Outlook (3rd Ed.)
This report explores which delivery formats drug innovators are using in their pipelines and portfolios, how likely innovators are to outsource manufacturing based on delivery device, and how these proportions will shift over the next five years.
Oral Dosage Forms Market Overview and Outlook (4th Edition)
This market research report provides an overview of the current market dynamics in the oral dose contract manufacturing space as well as an outlook of what our survey respondents—all oral dose outsourcing decision-makers at sponsor organizations—predict the marketplace will look like in 2024. Key statistics include oral dose project volume, percentage outsourced, and the average number of CMOs used to...
Clinical Manufacturing Market Dynamics and Service Provider Benchmarking
This report provides an overview of the current market dynamics in the clinical manufacturing space as well as an outlook of what our survey respondents predict the marketplace will look like in 2022.
Bioprocessing Market Trends and Outsourcing Dynamics: 2020-2025 (3rd Edition)
This market research report affords readers the opportunity to gain insight into the bioprocessing market and where it’s heading. This report provides an overview of the current market dynamics for bioprocessing as well as an outlook on what our survey respondents predict the marketplace will look like in five years.
Pharmaceutical Excipient Market Overview and Outlook
This market research report offers readers the opportunity to gain insight into the biopharmaceutical excipient market and where it’s heading. Remaining aware of market dynamics and expected changes will enable readers to better make key decisions regarding excipient use and to help identify where competitive advantages may be gained.
Development vs. Commercial Outsourced Manufacturing Practices: Small Molecule
This report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.
Development vs Commercial Outsourced Manufacturing Practices: Biologics
This market research report explores how the decision-making process differs among drug innovators outsourcing development activities from those outsourcing commercial manufacturing when it comes to CMO/CDMO selection criteria, use patterns, preferences and perceived leadership.
CONTRACT MANUFACTURER QUALITY BENCHMARKING
Biologic API CDMO Benchmarking (8th Ed.)
This report provides pharmaceutical companies and contract manufacturers a comprehensive analysis of current outsourcing trends and practices, in addition to a quantitative analysis of CDMO service quality.
Small Molecule API CDMO Benchmarking (8th Ed.)
This report will help biopharma companies make more informed CDMO decisions, and will help CDMOs optimize operational and marketing strategies.
Biologic Drug Product CDMO Benchmarking (6th Ed.)
This report offers insight into how individual CDMOs performed through analysis of 449 captured service encounters among 134 respondents who are involved in biologic drug product manufacturing.
Small Molecule Drug Product CDMO Benchmarking (6th Ed.)
This report contains data from 411 service encounters from 127 respondents who have been involved in outsourcing small molecule drug product projects in the past 18 months.
Biologic API CDMO Benchmarking For New & Emerging Pharma
This report is based on responses from 45 people involved in outsourced large molecule API projects over the last 18 months. It will help new/emerging pharma companies make informed CDMO selections, and help CDMOs better understand how they are perceived.
DEPARTMENT MODELS AND STRUCTURES
CDMO Outsourcing Models (4th Ed.)
This market research report explores how sponsor organizations use contract manufacturers to streamline costs, better manage capacity, access scientific expertise, improve efficiencies and decrease time to market.
Benchmarking the Pharma Industry’s Market Research Function
ISR conducted five in-depth interviews and 31 online surveys with experienced market researchers in the biopharmaceutical space to gain a better grasp on the market research function. Research subjects shared their insights on the types of research performed, how their market research function is structured, and outsourcing behavior.
The CMC Function: Best Practices and Optimization
ISR interviewed 15 CMC professionals at 14 Top 50 pharmaceutical and biotechnology companies, as well as one company outside the Top 50 to better understand the Chemistry Manufacturing and Controls function throughout the preclinical, clinical, and commercialization phases of the product development process.
Benchmarking The Pharma Industry’s Medical Science Liaison (MSL) Function
This market research report has been designed to be used as a benchmarking tool for companies to compare their Medical Science Liaison functions to those of other pharmaceutical and biotech organizations. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within...
Tracking The Evolution Of CDMO Selection Criteria
Year-over-year variation always exists in the selection criteria respondents prioritize in an outsourced manufacturer. Consider these five metrics when choosing a provider for biological drug substance manufacturing services.
How Industry Benchmarks Can Inform CDMO Selection
Commonly utilized as a market research tool, learn how performance benchmarking is helping to make CDMO selection less arduous.
Understanding The Art And Science Of Patient Recruitment
As clinical trials become increasingly complex, it is more important than ever to understand how to overcome patient recruitment challenges in order to accelerate timelines, lower costs, and improve the quality of clinical trial data.
Five Steps To CDMO Selection
How to establish a plan that identifies outsourcing drivers, select a model that matches company needs and resources, establish a decision-making process and group, and designate key selection criteria.
Where Bioprocessing Outsourcers Stand On Capacity Concerns
Insights into bioprocessing outsourcers’ level of concern regarding current and upcoming available capacity, whether they are currently facing limits, and what they plan to do about a potential shortage.
ABOUT ISR VIDEO
ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive:
- Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
- Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries. We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
- Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.
For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.